Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Cerebral and skin microcirculatory dysfunction in type 1 diabetes.

Kozera GM, Neubauer-Geryk J, Wolnik B, Szczyrba S, Wojczal J, Nyka WM, Bieniaszewski L.

Postepy Dermatol Alergol. 2019 Feb;36(1):44-50. doi: 10.5114/ada.2018.81185. Epub 2019 Jan 11.

2.

Cerebral thrombolysis in patients with ischemic stroke and heart failure.

Sobolewski P, Kozera G, Szczuchniak W, Sobota A, Chwojnicki K, Gruchała M, Nyka WM.

Neurol Neurochir Pol. 2018 Sep - Oct;52(5):593-598. doi: 10.1016/j.pjnns.2018.08.003. Epub 2018 Aug 17.

PMID:
30170703
3.

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients.

Gójska-Grymajło A, Zieliński M, Gąsecki D, Kowalczyk K, Kwarciany M, Seroczyńska B, Nyka WM.

Neuromolecular Med. 2018 Sep;20(3):301-311. doi: 10.1007/s12017-018-8494-x. Epub 2018 May 9.

4.

IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke.

Wytrykowska A, Prosba-Mackiewicz M, Nyka WM.

J Oral Sci. 2016;58(4):509-513. doi: 10.2334/josnusd.16-0278.

5.

Left ventricular ejection fraction and aortic stiffness are independent predictors of neurological outcome in acute ischemic stroke.

Rojek A, Gąsecki D, Fijałkowski M, Kowalczyk K, Kwarciany M, Wolf J, Nyka W, Boutouyrie P, Laurent S, Narkiewicz K.

J Hypertens. 2016 Dec;34(12):2441-2448.

PMID:
27607455
6.

Renal Dysfunction in Post-Stroke Patients.

Chwojnicki K, Król E, Wierucki Ł, Kozera G, Sobolewski P, Nyka WM, Zdrojewski T.

PLoS One. 2016 Aug 30;11(8):e0159775. doi: 10.1371/journal.pone.0159775. eCollection 2016.

7.

Intravenous thrombolysis and three-year ischemic stroke mortality.

Chwojnicki K, Kozera G, Sobolewski P, Fryze W, Nyka WM.

Acta Neurol Scand. 2017 May;135(5):540-545. doi: 10.1111/ane.12625. Epub 2016 Jun 22.

PMID:
27334369
8.

Acute hypertensive response in ischemic stroke is associated with increased aortic stiffness.

Kwarciany M, Gąsecki D, Kowalczyk K, Rojek A, Laurent S, Boutouyrie P, Skrzypek-Czerko M, Nyka WM, Narkiewicz K, Karaszewski B.

Atherosclerosis. 2016 Aug;251:1-5. doi: 10.1016/j.atherosclerosis.2016.04.027. Epub 2016 May 7.

PMID:
27214693
9.

Statin Use and Cognitive Impairment in Patients With Type 1 Diabetes: An Observational Study.

Moryś JM, Kozera GM, Neubauer-Geryk J, Kruszewski P, Wolnik B, Nyka WM, Bieniaszewski L.

Clin Neuropharmacol. 2016 Jul-Aug;39(4):182-7. doi: 10.1097/WNF.0000000000000158.

PMID:
27046662
10.

Long-term mortality after stroke is higher than after myocardial infarction.

Chwojnicki K, Wierucki Ł, Zagożdżon P, Wojtyniak B, Nyka WM, Zdrojewski T.

Neurol Sci. 2016 Jun;37(6):891-8. doi: 10.1007/s10072-016-2502-4. Epub 2016 Feb 10.

11.

The role of additional computed tomography in the decision-making process on the secondary prevention in patients after systemic cerebral thrombolysis.

Sobolewski P, Kozera G, Szczuchniak W, Nyka WM.

Ther Clin Risk Manag. 2015 Dec 23;12:5-10. doi: 10.2147/TCRM.S91119. eCollection 2016.

12.

Interval analysis of interictal EEG: pathology of the alpha rhythm in focal epilepsy.

Pyrzowski J, Siemiński M, Sarnowska A, Jedrzejczak J, Nyka WM.

Sci Rep. 2015 Nov 10;5:16230. doi: 10.1038/srep16230.

13.

Clinical utility of chosen factors in predicting post-stroke depression: a one year follow-up.

Wichowicz HM, Gąsecki D, Landowski J, Lass P, Świerkocka M, Wiśniewski G, Nyka WN, Wilkowska A.

Psychiatr Pol. 2015;49(4):683-96. doi: 10.12740/PP/38439. English, Polish.

14.

Length of stay in emergency department and cerebral intravenous thrombolysis in community hospitals.

Szczuchniak W, Kozera G, Sobolewski P, Brola W, Staszewski J, Schminke U, Nyka WM; Pomeranian Stroke Registry collaborators.

Eur J Emerg Med. 2017 Jun;24(3):208-216. doi: 10.1097/MEJ.0000000000000330.

PMID:
26479737
15.

Efficacy of cerebral thrombolysis in an extended 'time window'.

Sobolewski P, Kozera G, Kaźmierski R, Michalak S, Szczuchniak W, Nyka W.

J Clin Pharm Ther. 2015 Aug;40(4):472-6. doi: 10.1111/jcpt.12292. Epub 2015 Jun 7.

PMID:
26059848
16.

Diabetic symmetric polyneuropathy is associated with increased aortal stiffening but not cerebral angiopathy in type 1 diabetes.

Szczyrba S, Kozera GM, Neubauer-Geryk J, Wolnik B, Nyka WM, Bieniaszewski L.

J Diabetes Complications. 2015 Jan-Feb;29(1):73-6. doi: 10.1016/j.jdiacomp.2014.10.002. Epub 2014 Nov 3.

PMID:
25456818
17.

Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation.

Halon M, Kaczor JJ, Ziolkowski W, Flis DJ, Borkowska A, Popowska U, Nyka W, Wozniak M, Antosiewicz J.

Free Radic Res. 2014 Nov;48(11):1363-70. doi: 10.3109/10715762.2014.955484. Epub 2014 Sep 11.

PMID:
25175826
18.

First non-complicated thrombolysis in a young patient with Marfan syndrome and brainstem ischaemic stroke.

Gójska-Grymajło A, Chwojnicki K, Nyka WM.

Kardiol Pol. 2014;72(6):557. doi: 10.5603/KP.2014.0125. No abstract available.

19.

Is there a bad time for intravenous thrombolysis? The experience of Polish stroke centers.

Karliński M, Kobayashi A, Sobolewski P, Lisewski P, Romanowicz S, Fryze W, Nyka W, Zięba M, Dorobek M, Członkowska A.

Neurol Neurochir Pol. 2014 Jan-Feb;48(1):45-51. doi: 10.1016/j.pjnns.2013.12.003. Epub 2014 Jan 23.

PMID:
24636770
20.

Comment to article: Semi-automatic assessment of skin capillary density: proof of principle and validation.

Neubauer-Geryk J, Kozera GM, Nyka WM, Bieniaszewski L.

Microvasc Res. 2014 May;93:21-2. doi: 10.1016/j.mvr.2014.02.010. Epub 2014 Mar 1. No abstract available.

PMID:
24594439
21.

Hypertension, brain damage and cognitive decline.

Gąsecki D, Kwarciany M, Nyka W, Narkiewicz K.

Curr Hypertens Rep. 2013 Dec;15(6):547-58. doi: 10.1007/s11906-013-0398-4. Review.

22.

Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach.

Graff B, Gąsecki D, Rojek A, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K.

J Hypertens. 2013 Aug;31(8):1629-36. doi: 10.1097/HJH.0b013e328361e48b.

PMID:
23751963
23.

Intravenous rt-PA in patients with ischaemic stroke and renal dysfunction.

Sobolewski P, Kozera G, Kaźmierski R, Michalak S, Szczuchniak W, Śledzińska-Dźwigał M, Nyka WM.

Clin Neurol Neurosurg. 2013 Sep;115(9):1770-4. doi: 10.1016/j.clineuro.2013.04.006. Epub 2013 May 1.

PMID:
23643179
24.

Authors' response to a letter from Vidale and Agostoni.

Kozera G, Chwojnicki K, Gójska-Grymajło A, Gąsecki D, Schminke U, Nyka WM; Pomeranian Stroke Register collaborators.

Acta Neurol Scand. 2013 Mar;127(3):e15-6. doi: 10.1111/ane.12056. No abstract available.

PMID:
23410067
25.

Decreased reactivity of skin microcirculation in response to L-arginine in later-onset type 1 diabetes.

Neubauer-Geryk J, Kozera GM, Wolnik B, Szczyrba S, Nyka WM, Bieniaszewski L.

Diabetes Care. 2013 Apr;36(4):950-6. doi: 10.2337/dc12-0320. Epub 2012 Nov 12.

26.

Pulse wave velocity is associated with early clinical outcome after ischemic stroke.

Gąsecki D, Rojek A, Kwarciany M, Kowalczyk K, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K.

Atherosclerosis. 2012 Dec;225(2):348-52. doi: 10.1016/j.atherosclerosis.2012.09.024. Epub 2012 Oct 3. Erratum in: Atherosclerosis. 2013 Jul;229(1):271-2.

PMID:
23083680
27.

Angiogenin in middle-aged type 1 diabetes patients.

Neubauer-Geryk J, Kozera GM, Wolnik B, Szczyrba S, Nyka WM, Bieniaszewski L.

Microvasc Res. 2012 Nov;84(3):387-9. doi: 10.1016/j.mvr.2012.08.005. Epub 2012 Aug 30.

PMID:
22940420
28.

Increased frequency of restless legs syndrome in myasthenia gravis.

Sieminski M, Bilińska M, Nyka WM.

Eur Neurol. 2012;68(3):166-70. Epub 2012 Aug 14.

PMID:
22906874
29.

CD34/CXCR4 stem cell dynamics in acute stroke patients.

Gójska-Grymajło A, Nyka WM, Zieliński M, Jakubowski Z.

Folia Neuropathol. 2012;50(2):140-6.

30.

Hemodynamic findings in patients with brain stroke.

Siebert J, Gutknecht P, Molisz A, Trzeciak B, Nyka W.

Arch Med Sci. 2012 May 9;8(2):371-4. doi: 10.5114/aoms.2012.28567.

31.

Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland.

Karliński M, Kobayashi A, Litwin T, Sobolewski P, Fryze W, Romanowicz S, Glonek M, Nyka W, Lisewski P, Członkowska A; SITS Poland Collaborative Group.

Neurol Neurochir Pol. 2012 Jan-Feb;46(1):3-14.

PMID:
22426757
32.

[Expert opinion on use of intravenous immunoglobulins in the management of neurological disorders].

Stępień A, Korsak J, Kozubski W, Ryglewicz D, Losy J, Drozdowski W, Kotowicz J, Nyka W, Kwieciński H.

Neurol Neurochir Pol. 2011 Nov-Dec;45(6):525-35. Polish. No abstract available.

PMID:
22212982
33.

Pre-hospital delays and intravenous thrombolysis in urban and rural areas.

Kozera G, Chwojnicki K, Gójska-Grymajło A, Gąsecki D, Schminke U, Nyka WM; Pomeranian Stroke Register collaborators.

Acta Neurol Scand. 2012 Sep;126(3):171-7. doi: 10.1111/j.1600-0404.2011.01616.x. Epub 2011 Nov 11.

PMID:
22077692
34.

Aortic stiffness predicts functional outcome in patients after ischemic stroke.

Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K.

Stroke. 2012 Feb;43(2):543-4. doi: 10.1161/STROKEAHA.111.633487. Epub 2011 Nov 10.

PMID:
22076001
35.

[Diagnostic difficulties in myasthenia gravis].

Bilińska M, Nyka WM.

Pol Merkur Lekarski. 2011 Apr;30(178):277-82. Review. Polish.

PMID:
21595175
36.

Assessment of the quality of secondary ischemic stroke prevention in selected urban areas of Poland and Ukraine: the ASCEP study results.

Chwojnicki K, Yagensky A, Wierucki L, Sichkaruk I, Sydor N, Nyka WM, Wyrzykowski B, Zdrojewski T.

Eur Neurol. 2011;65(6):323-31. doi: 10.1159/000327576. Epub 2011 May 17.

PMID:
21576969
37.

Cerebral vasomotor reactivity and extent of white matter lesions in middle-aged men with arterial hypertension: a pilot study.

Kozera GM, Dubaniewicz M, Zdrojewski T, Madej-Dmochowska A, Mielczarek M, Wojczal J, Chwojnicki K, Swierblewska E, Schminke U, Wyrzykowski B, Nyka WM; SOPKARD Study Group.

Am J Hypertens. 2010 Nov;23(11):1198-203. doi: 10.1038/ajh.2010.152. Epub 2010 Jul 22.

PMID:
20651697
38.

The association between arterial stiffness and cerebral flow parameters. Letter.

Kozera GM, Neubauer-Geryk J, Nyka WM, Bieniaszewski L.

Blood Press. 2010 Apr;19(2):126. doi: 10.3109/08037050903561041. No abstract available.

PMID:
20121382
39.

Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.

Kobayashi A, Czlonkowska A, Ahmed N, Romanowicz S, Glonek M, Nyka WM, Opala G, Wahlgren N; SITS Poland Collaborative Group.

Acta Neurol Scand. 2010 Oct;122(4):229-36. doi: 10.1111/j.1600-0404.2009.01294.x. Epub 2009 Nov 16.

PMID:
19919643
40.

Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation.

Halon M, Sielicka-Dudzin A, Wozniak M, Ziolkowski W, Nyka W, Herbik M, Grieb P, Figarski A, Antosiewicz J.

Neuromuscul Disord. 2010 Jan;20(1):29-33. doi: 10.1016/j.nmd.2009.08.014. Epub 2009 Nov 11.

PMID:
19910193
41.

Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes.

Kozera GM, Wolnik B, Kunicka KB, Szczyrba S, Wojczal J, Schminke U, Nyka WM, Bieniaszewski L.

Diabetes Care. 2009 May;32(5):878-82. doi: 10.2337/dc08-1805. Epub 2009 Feb 19.

42.

Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland.

Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B.

Clin Biochem. 2009 Apr;42(6):442-7. doi: 10.1016/j.clinbiochem.2008.12.019. Epub 2009 Jan 6.

PMID:
19166826
43.

Neuropsychological assessment in myasthenia gravis.

Sitek EJ, Bilińska MM, Wieczorek D, Nyka WM.

Neurol Sci. 2009 Feb;30(1):9-14. doi: 10.1007/s10072-008-0001-y. Epub 2009 Jan 16.

PMID:
19148573
44.

Anaesthesia for ophthalmologic surgical procedures in a patient with advanced amyotrophic lateral sclerosis: a case report.

Kowalik MM, Smiatacz T, Pajuro R, Skowroński R, Trocha H, Nyka W, Raczyńska K, Wujtewicz M.

Cases J. 2008 Nov 20;1(1):338. doi: 10.1186/1757-1626-1-338.

45.

Risk factors of sensorineural hearing loss in patients with ischemic stroke.

Przewoźny T, Gasecki D, Narozny W, Nyka W.

Otol Neurotol. 2008 Sep;29(6):745-50. doi: 10.1097/MAO.0b013e318181336c.

PMID:
18636032
46.

Unaffected patients with a homozygous absence of the SMN1 gene.

Jedrzejowska M, Borkowska J, Zimowski J, Kostera-Pruszczyk A, Milewski M, Jurek M, Sielska D, Kostyk E, Nyka W, Zaremba J, Hausmanowa-Petrusewicz I.

Eur J Hum Genet. 2008 Aug;16(8):930-4. doi: 10.1038/ejhg.2008.41. Epub 2008 Mar 12.

47.

Percutaneous tracheostomy in patients with disorders of the central nervous system.

Witkowska M, Kaczmarek E, Graff M, Karwacki Z, Słoniewski P, Nyka W.

Neurol Neurochir Pol. 2007 Nov-Dec;41(6):504-9.

PMID:
18224572
48.

Two-dimensional LC-MS/MS in detection of peptides in hypothalamus of the rat subjected to hypoxic stress.

Mihailova A, Karaszewski B, Faergestad EM, Hauser R, Nyka WM, Lundanes E, Greibrokk T.

J Sep Sci. 2008 Feb;31(3):468-79. doi: 10.1002/jssc.200700269.

PMID:
18210376
49.

Improved HPLC method for total plasma homocysteine detection and quantification.

Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B.

Acta Biochim Pol. 2008;55(1):119-25. Epub 2008 Jan 16.

50.

[The comparison of selected spirometric parameters with functional muscles exercise evaluation in patients with myasthenia].

Mincewicz G, Aloszko A, Nyka W, Bilińska M, Krzykowski G, Nyka WM.

Pol Merkur Lekarski. 2007 Mar;22(129):177-81. Polish.

PMID:
17682670

Supplemental Content

Support Center